Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark.

0
173

Nasdaq Biotech Index up almost 3% after FDA approved Biogen's Alzheimer drug in disease landmark. h/t Holger Zschaepitz

Nasdaq Biotech Index up almost 3% after FDA approved Biogen's Alzheimer drug in disease landmark.

Our Twitter for Quick Updates: Twitter Follow Us

LEAVE A REPLY

Please enter your comment!
Please enter your name here

5 × 4 =

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.